An at-home pill against coronavirus halves the chance that people newly diagnosed with COVID-19 will land in the hospital or die, early results released by the drug’s developer ...

The antiviral drug ensitrelvir prevents infection in household contacts of COVID-19 patients when given within 72 hours after symptom onset in the index patient, according to a Phase III randomized ...

A doctor hands Molnupiravir, an antiviral medication used to treat Coronavirus COVID-19, to a patient in Tokyo on Jan. 9, 2022. Senior Correspondent With the Omicron variant still circulating widely ...

The UK has received a supply of favipiravir from the Japanese government to aid Hantavirus preparedness.

No antivirals are approved as postexposure prophylaxis for household contacts of people with COVID-19. In this randomized study, 2.9% of household contacts who took ensitrelvir developed COVID within ...

Pfizer’s Covid-19 antiviral Paxlovid and Merck’s coronavirus pill molnupiravir appear to guard against hospitalizations and death even when people aren't experiencing severe symptoms, a new study ...